Efficacy of tolvaptan in patients hospitalized for heart failure with refractory hyponatremia. Clinical experience in daily practice

Rev Esp Cardiol (Engl Ed). 2013 Jun;66(6):503-4. doi: 10.1016/j.rec.2012.12.015. Epub 2013 Apr 11.

Authors

Nahikari Salterain-Gonzalez¹, Alberto Esteban-Fernández², Martín García-López³, Francisco J Lavilla-Royo³, Juan J Gavira-Gómez¹

Affiliations

¹ Unidad de Insuficiencia Cardiaca, Departamento de Cardiología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
² Unidad de Insuficiencia Cardiaca, Departamento de Cardiología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. Electronic address: athalbertus@gmail.com.
³ Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.

PMID: 24776057
DOI: 10.1016/j.rec.2012.12.015

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antidiuretic Hormone Receptor Antagonists / adverse effects
Antidiuretic Hormone Receptor Antagonists / therapeutic use*
Benzazepines / adverse effects
Benzazepines / therapeutic use*
Drug Resistance
Female
Heart Failure / complications
Heart Failure / drug therapy*
Humans
Hyponatremia / complications
Hyponatremia / drug therapy*
Male
Middle Aged
Retrospective Studies
Tolvaptan
Water-Electrolyte Balance

Substances

Antidiuretic Hormone Receptor Antagonists
Benzazepines
Tolvaptan